⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Official Title: A Phase 3, Randomized, Open-label Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) After Failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy (HERTHENA-Lung02)

Study ID: NCT05338970

Study Description

Brief Summary: Disease progression is typical for patients with epidermal growth factor receptor mutated (EGFRm) non-small cell lung cancer (NSCLC). Standard platinum-based chemotherapy offers limited efficacy and an unfavorable safety profile.There is an urgent need for more effective and tolerable therapies for patients with EGFRm NSCLC who have exhausted available targeted therapies. Clinical evidence suggest that patritumab deruxtecan constitutes a promising investigational therapy for patients with EGFRm NSCLC.

Detailed Description: Patritumab deruxtecan (HER3-DXd, U3-1402) is an antibody-drug conjugate (ADC) comprising an anti-HER3 mAb linked to a topoisomerase I inhibitor that is in clinical development for patients with NSCLC, metastatic breast cancer, and colorectal cancer. The primary objective of the current study is to compare the efficacy of patritumab deruxtecan versus platinum-based chemotherapy, as measured by progression-free survival (PFS) and the key secondary endpoint of overall survival (OS), in participants with metastatic or locally advanced NSCLC with an EGFR-activating mutation (exon 19 deletion or L858R) after failure of third-generation (eg, osimertinib, lazertinib, aumolertinib, alflutinib) EGFR TKI therapy.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States

Highlands Oncology, Springdale, Arkansas, United States

City of Hope, Duarte, California, United States

Moores Cancer Center at the UC San Diego Health, La Jolla, California, United States

Scripps MD Anderson Cancer Center, La Jolla, California, United States

USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

Kaiser Permanente - Vallejo Medical Center, Vallejo, California, United States

Innovative Clinical Research Institute, Whittier, California, United States

Sarah Cannon/Florida Cancer Specialists - FCS South, Port Charlotte, Florida, United States

Emory University, Atlanta, Georgia, United States

St Luke's Cancer Institute, Boise, Idaho, United States

American Oncology Partners of Maryland, Bethesda, Maryland, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Hackensack Meridian Health-Southern Ocean Medical Center, Manahawkin, New Jersey, United States

Montefiore Medical Center, Bronx, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Providence Portland Medical Center, Portland, Oregon, United States

Sarah Cannon Research Institute, Nashville, Tennessee, United States

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Inova Schar Cancer Institute, Fairfax, Virginia, United States

Virginia Cancer Specialists, Fairfax, Virginia, United States

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

The Chris O'Brien Lifehouse, Camperdown, , Australia

St George Public Hospital, Kogarah, , Australia

Liverpool Hospital, Liverpool, , Australia

Austin Hospital, Melbourne, , Australia

St John of God Subiaco Hospital, Subiaco, , Australia

Princess Alexandra Hospital, Woolloongabba, , Australia

Landeskrankenhaus Feldkirch, Feldkirch, , Austria

Medizinische Universitaet Innsbruck, Innsbruck, , Austria

Klinikum Klagenfurt Pulmologie, Klagenfurt, , Austria

Klinikum Wels-Grieskirchen, Wels, , Austria

Karl Landsteiner Institut fur Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf, Wien, , Austria

Cliniques Universitaires Saint-Luc, Brussels, , Belgium

UZ Leuven, Leuven, , Belgium

AZ Sint Maarten Mechelen, Mechelen, , Belgium

AZ Delta, Roeselare, , Belgium

William Osler Health System - Brampton Civic Hospital, Brampton, , Canada

Peking University Cancer Hospital, Beijing, , China

Jilin Cancer Hospital, Chang chun, , China

Hunan Cancer Hospital, Changsha, , China

University of Electronic Science Technology of China UESTC - Sichuan Cancer Hospital Institute Sichuan Provincial Tumor Hospital, Chengdu, , China

National Cancer Center Hospital East, Chibi, , China

Fujian Medical University - Union Hospital Foochow Christian Union Hospital, Fuzhou, , China

Guangdong Academy of Medical Science (GAMS) - Guangdong Provincial Peoples Hospital, Guangzhou, , China

The First Affiliated Hospital Sun-Yat-Sen University, Guangzhou, , China

Pecking University Third Hospital, Haidian, , China

The First Affiliated Hospital of College of Medicine Zhejiang University, Hangzhou, , China

Zhejiang Cancer hospital, Hangzhou, , China

Harbin Medical University - Tumor Hospital The Third Affiliated Hospital, Harbin, , China

The First Affiliated Hospital - Anhui Medical University Dept of Medical Oncology, Hefei, , China

Henan Provincial Peoples Hospital, Henan, , China

The Second Affiliated Hospital of Kunming Medical University, Kunming, , China

Lin Yi Cancer Hospital, Linyi, , China

General Hospital of Eastern Theater Command, Nanjing, , China

The First Affiliated Hospital of Guangxi Medical University, Nanning, , China

Fudan University - Shanghai Cancer Center FUSCC, Shanghai, , China

Cancer Hospital of Shantou University Medical College, Shantou, , China

The First Hospital of China Medical University, Shenyang, , China

Union Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, , China

Huazhong University of Science and Technology - Tongji Medical College - Tongji Hospital TJH, Wuhan, , China

The First Affiliate Hospital of Xi'an Jiaotong University, Xi'an, , China

Henan Cancer Hospital, Zhengzhou, , China

Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, , China

Hopital Morvan CHU de Brest, Brest, , France

Centre Francois Baclesse, Caen, , France

Centre Francois Baclesse, Caen, , France

Centre Leon Berard, Lyon, , France

Montpellier Cancer Institute ICM, Montpellier, , France

Institut Curie, Paris Cedex 05, , France

APHP - Hopital Saint Louis, Paris, , France

Centre Hospitalier Lyon Sud, Pierre-Bénite, , France

Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou, Rennes, , France

Institut de Cancrologie de lOuest ICO, Saint-Herblain, , France

Gustave Roussy, Villejuif, , France

Universitaetsklinikum Essen, Essen, , Germany

Klinikum Esslingen GmbH, Esslingen, , Germany

IKF Krankenhaus Nordwest, Frankfurt am main, , Germany

Asklepios Fachklinik Muenchen-Gauting, Gauting, , Germany

Universitatsklinik Giessen und Marburg, Gießen, , Germany

LungenClinic Grosshansdorf, Großhansdorf, , Germany

Thoraxklinik Heidelberg gGmbH, Heidelberg, , Germany

LKI Lungenfachklinik Immenhausen, Immenhausen, , Germany

Klinikverbund Allgaeu, Kempten, , Germany

Pius-Hospital Oldenburg, Oldenburg, , Germany

Pamela Youde Nethersole Eastern Hospital, Hong Kong, , Hong Kong

Prince of Wales Hospital, Hong Kong, , Hong Kong

University of Hong Kong/Queen Mary Hospital, Hong Kong, , Hong Kong

Queen Elizabeth Hospital, Hong Kong, , Hong Kong

IRCCS Istituto Oncologico Giovanni Paolo II, Bari, , Italy

University G. D'Annunzio Chieti, Chieti, , Italy

Ospedale San Luca, Lucca, , Italy

IRCCS Istituto Europeo di Oncologia, Milano, , Italy

Asst Grande Ospedale Metropolitano Niguarda, Milano, , Italy

Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, , Italy

Azienda Ospedaliero Universitaria di Parma, Parma, , Italy

Ospedale Santa Maria della Misericordia, Perugia, , Italy

IFO Regina Elena, Roma, , Italy

IRCCS Humanitas Research Hospital, Rozzano, , Italy

ASST Sette Laghi, Varese, , Italy

Hyogo Cancer Center, Akashi, , Japan

Kyushu University Hospital, Fukuoka, , Japan

Saitama Medical University International Medical Center, Hidaka, , Japan

Kansai Medical University Hospital, Hirakata, , Japan

Iwakuni Clinical Center, Iwakuni, , Japan

Izumi City General Hospital, Izumi, , Japan

Kanazawa University Hospital, Kanazawa, , Japan

The Cancer Institute Hospital of JFCR, Koto-Ku, , Japan

Saiseikai Kumamoto Hospital, Kumamoto, , Japan

Kurashiki Central Hospital, Kurashiki, , Japan

Kurume University Hospital, Kurume, , Japan

Matsusaka Municipal Hospital, Matsusaka, , Japan

NHO Shikoku Cancer Center, Matsuyama, , Japan

National Hospital Organization Nagoya Medical Center, Nagoya, , Japan

Niigata Cancer Center Hospital, Niigata, , Japan

Okayama University Hospital, Okayama, , Japan

National Hospital Organization Hokkaido Cancer Center, Sapporo, , Japan

Sendai Kousei Hospital, Sendai, , Japan

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, , Japan

Fujita Health University Hospital, Toyoake, , Japan

Wakayama Medical University Hospital, Wakayama, , Japan

Kindai University Hospital, Ōsaka-sayama, , Japan

Chungbuk National University Hospital, Cheongju-si, , Korea, Republic of

National Cancer Center, Goyang, , Korea, Republic of

Seoul National University Bundang Hospital, Seongnam, , Korea, Republic of

Seoul National University Hospital, Seoul, , Korea, Republic of

Severance Hospital, Seoul, , Korea, Republic of

Asan Medical Center, Seoul, , Korea, Republic of

Samsung Medical Center, Seoul, , Korea, Republic of

The Catholic University of Korea, Seoul St. Marys Hospital, Seoul, , Korea, Republic of

Samsung Medical Center, Seoul, , Korea, Republic of

Netherlands Cancer Institute, Amsterdam, , Netherlands

Rijnstate Ziekenhuis, Arnhem, , Netherlands

St. Jansdal Ziekenhuis, Harderwijk, , Netherlands

Leiden University Medical Center, Leiden, , Netherlands

Erasmus MC, Rotterdam, , Netherlands

University Medical Center Utrecht, Utrecht, , Netherlands

Akershus University Hospital, Nordbyhagen, , Norway

Oslo University Hospital-The Norwegian Radium Hospital, Oslo, , Norway

Stavanger University Hospital, Stavanger, , Norway

II Klinika Chorob Pluc i Gruzlicy, Białystok, , Poland

Onko-Centrum Sp. z o.o., Lublin, , Poland

Med Polonia Sp. z o.o., Poznań, , Poland

Centro Clinico Champalimaud, Lisboa, , Portugal

Instituto Portugues de Oncologio de Lisboa, Lisbon, , Portugal

Centro Hospitalar Universitario do Porto - Hospital de Santo Antonio, Porto, , Portugal

Centro Hospitalar de Vila Nova de Gaia - Espinho, Porto, , Portugal

National University Cancer Institute National University Hospital, Singapore, , Singapore

National Cancer Centre Singapore NCCS, Singapore, , Singapore

Tan Tock Seng Hospital, Singapore, , Singapore

ICON Cancer Centre, Singapore, , Singapore

Hospital Teresa Herrera C.H.U.A.C., A Coruña, , Spain

Hospital del Mar, Barcelona, , Spain

Hospital Universitari Vall d'Hebron, Barcelona, , Spain

Hospital Clinic i Provincial de Barcelona, Barcelona, , Spain

Complejo Hospitalario Materno-Insular - Hospital Insular de Gran Canaria, Las Palmas De Gran Canaria, , Spain

Hospital General Universitario Gregorio Maranon, Madrid, , Spain

MD Anderson Cancer Center, Madrid, , Spain

Hospital Universitario Fundacion Jimenez Diaz, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Regional Universitario Malaga, Málaga, , Spain

Hospital Univeritario Marques de Valdecilla, Santander, , Spain

Hospital Universitario Virgen Macarena, Sevilla, , Spain

Hospital Universitario Virgen Macarena, Sevilla, , Spain

Kantonsspital Graubuenden - Hauptstandort, Chur, , Switzerland

Kantonsspital Winterthur KSW, Winterthur, , Switzerland

E-Da Hospital, Kaohsiung City, , Taiwan

Taichung Veterans General Hospital, Taichung, , Taiwan

National Cheng Kung University Hospital NCKUH, Tainan, , Taiwan

National Taiwan University Hospital NTUH, Taipei, , Taiwan

Taipei Veterans General Hospital, Taipei, , Taiwan

Chang Gung Memorial Hospital-Linkou Branch, Taoyuan, , Taiwan

University Hospital Birmingham NHS Trust, Birmingham, , United Kingdom

Beatson West of Scotland Cancer Centre, Glasgow, , United Kingdom

Leeds Cancer Centre, Leeds, , United Kingdom

University Hospitals of Leicester, Leicester, , United Kingdom

Barts and The London NHS Trust - St Bartholomew s hospital - PET CT Centre, London, , United Kingdom

The Royal Marsden Hospital NHS Foundation Trust, London, , United Kingdom

The Royal Marsden NHS Foundation Trust, London, , United Kingdom

The Christie Hospital, Manchester, , United Kingdom

The Royal Wolverhampton NHS Trust, Wolverhampton, , United Kingdom

Contact Details

Name: Global Clinical Leader

Affiliation: Daiichi Sankyo

Role: STUDY_DIRECTOR

Name: Clinical Scientist

Affiliation: Daiichi Sankyo

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: